| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$7 |
Proposed issue of securities - ACM
|
29 Jan 2026 9:24AM |
$0.081 |
$0.062 |
fallen by
23.46%
|
|
| Broken Hill Mines Limited (BHM) ORDINARY FULLY PAID |
Materials |
$104 |
December Quarterly Results Presentation
|
29 Jan 2026 9:24AM |
$1.290 |
$0.640 |
fallen by
50.39%
|
|
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$7 |
$3M Placement
|
29 Jan 2026 9:24AM |
$0.081 |
$0.062 |
fallen by
23.46%
|
|
ACM - Price-sensitive ASX Announcement
Full Release
Key Points
- Australian Critical Minerals Limited (ACM) announced a $3 million placement.
- The placement will fund exploration activities in Peru, including drilling at the Flint Gold-Silver Project.
- The Flint Project is a high-sulphidation epithermal gold-silver system located in Peru.
- ACM plans to issue 40 million new shares at $0.075 each to raise the funds.
- The placement will occur in two tranches, with Tranche 1 expected in early February 2026.
- Tranche 2 is subject to shareholder approval, to be sought in March 2026.
- Sandton Capital Advisory Pty Ltd will manage the placement and receive a 6% fee.
- The funds will also support ACM's general working capital needs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bannerman Energy Ltd (BMN) ORDINARY FULLY PAID |
Energy |
$696 |
Appendix 5B - Quarterly Cash Flow Report
|
29 Jan 2026 9:24AM |
$4.730 |
$3.350 |
fallen by
29.18%
|
|
BMN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities: $2,435,000
- Net cash outflow from investing activities: $20,078,000
- Cash inflow from equity securities: $85,000
- Net cash outflow from financing activities: $71,000
- Cash and cash equivalents at quarter end: $89,278,000
- Estimated 9.4 quarters of funding available
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winsome Resources Limited (WR1) ORDINARY FULLY PAID |
Materials |
$77 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 9:24AM |
$0.635 |
$0.315 |
fallen by
50.39%
|
|
WR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Winsome Resources Limited entered into a binding Scheme Implementation Deed with Li-FT Power Limited for acquisition.
- Shareholders of Winsome will receive 0.107 of a Li-FT common share for each ordinary share of Winsome held.
- Winsome sold its offtake rights to lithium, cesium, and tantalum from the Case Lake Area to a subsidiary of Albemarle Corporation for C$1.8 million.
- Winsome has A$7.0 million in cash and 26.83 million shares in PWM valued at C$22.0 million as of December 31, 2025.
- Winsome secured an option to acquire additional claims adjoining the Adina project, covering 20km2.
- No major health and safety incidents occurred during 2025 field season.
- Infill drilling at Adina returned further high-grade, shallow intercepts.
- Eskan Consulting Group signed a Contribution Agreement with Natural Resources Canada for funding the Trans-Atikh Project.
- Net cash used in operating activities was A$4.3 million for the last six months ending December 2025.
- Net cash used in investing activities was A$7.0 million for the same period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Q2 FY26 Quarterly Investor Presentation & Webinar
|
29 Jan 2026 9:23AM |
$0.085 |
$0.072 |
fallen by
15.29%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Core testing volumes up 90% year-over-year.
- Discontinued legacy products to focus on high-margin offerings.
- Developing a rich pipeline of live biotherapeutic assets.
- Microbiome Explorer adoption outperforming in the UK.
- Strategic focus on partnering for therapeutic developments.
- Advancements in diagnostics for gastrointestinal diseases.
- Building platform for personalized, microbiome-based healthcare.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ionic Rare Earths Limited (IXR) ORDINARY FULLY PAID |
Materials |
$63 |
December Quarterly Activities & Cash Flow Report
|
29 Jan 2026 9:23AM |
$0.545 |
$0.280 |
fallen by
48.62%
|
|
IXR - Price-sensitive ASX Announcement
Full Release
Key Points
- IonicRE emphasized the strategic importance of the Makuutu Heavy Rare Earths Project in Uganda.
- A mining licence for the Makuutu project was awarded, and the project is 'shovel-ready' for production.
- Ionic Technologies in the UK received a £12 million grant offer for its Belfast commercial plant.
- The company is advancing discussions on creating an ex-China rare earth supply chain.
- Significant financing activity included a successful rights issue and strategic investments.
- A capital consolidation was completed, reducing the number of shares.
- Corporate costs included expenditures on demonstration and exploratory activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Equatorial Resources Limited (EQX) ORDINARY FULLY PAID |
Materials |
$26 |
December 2025 Quarterly Report
|
29 Jan 2026 9:23AM |
$0.185 |
$0.195 |
risen by
5.41%
|
|
EQX - Price-sensitive ASX Announcement
Full Release
Key Points
- Equatorial Resources Limited presented its quarterly report for the period ending 31 December 2025.
- The company is engaged in an international arbitration against the Republic of Congo, regarding two iron ore projects.
- Final hearing for the arbitration was completed, with post-hearing submissions due in early 2026.
- Equatorial is claiming damages from Congo ranging from US$395 million to US$1.25 billion.
- The arbitration arose from unlawful measures taken by Congo against Equatorial's investments.
- Equatorial's financial position includes approximately $8.1 million in cash.
- The company is seeking clarity on its exploration permits in Guinea.
- Equatorial remains open to settlement discussions with Congo regarding the dispute.
- No payments were made for mining exploration activities during the quarter.
- Equatorial has interests in several mining exploration permits, some of which are awaiting renewal.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,613 |
Quarterly Activities Report - Dec 31, 2025
|
29 Jan 2026 9:22AM |
$6.340 |
$4.900 |
fallen by
22.71%
|
|
CIA - Price-sensitive ASX Announcement
Full Release
Key Points
- Champion Iron Limited reports its operational and financial results for the financial third quarter ended December 31, 2025.
- The quarterly production was 3.7 million wmt of high-grade 66.5% Fe concentrate.
- Champion Iron generated revenues of $472 million and net income of $65 million.
- DRPF project initial commissioning is underway with plans to deliver the first shipment by the end of calendar H1/2026.
- The company plans to diversify its portfolio with the acquisition of Rana Gruber.
- Champion Iron anticipates the Kami project definitive feasibility study to be completed by the end of the 2026 calendar year.
- The company reduced iron ore concentrate inventories at Bloom Lake by 1.1 million wmt.
- Champion continues to evaluate growth opportunities and capital allocation strategies to optimize shareholder returns.
- A webcast and conference call to discuss the results was scheduled for January 29, 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Archer Materials Limited (AXE) ORDINARY FULLY PAID |
Information Technology |
$79 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 9:22AM |
$0.390 |
$0.310 |
fallen by
20.51%
|
|
AXE - Price-sensitive ASX Announcement
Full Release
Key Points
- Improved quantum state readout for Archer’s carbon qubit materials.
- Signed a collaboration agreement with Emergence Quantum.
- Agreement with CSIRO to develop quantum machine learning models.
- Biochip met clinical standards for blood potassium testing.
- End of quarter cash balance of $10.3 million, with no debt.
- Appointment of Andrew Just as Non-Executive Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Loyal Metals Ltd (LLM) ORDINARY FULLY PAID |
Materials |
$41 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 9:22AM |
$0.305 |
$0.270 |
fallen by
11.48%
|
|
LLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Secured a binding option to acquire Highway Reward Copper Gold Mine.
- Completed a $3.5 million share placement.
- Verified significant unmined copper-gold mineralization.
- Net cash outflow from operations was $1.791 million.
- Total funding available at quarter-end was $6.11 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$29,057 |
Acknowledgement of Class Action Filing
|
29 Jan 2026 9:22AM |
$20.990 |
$21.650 |
risen by
3.14%
|
|
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Q2 FY26 Quarterly Activities Report & Appendix 4C
|
29 Jan 2026 9:21AM |
$0.085 |
$0.072 |
fallen by
15.29%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Core testing revenue increased by 123% compared to the previous year.
- Transition to higher-margin Invivo branded supplements contributed to growth.
- Legacy product lines have been discontinued, affecting short-term cash flow.
- Operational efficiencies improved through cost restructuring and lab consolidation.
- Significant growth in Microbiome Explorer tests, especially in the UK.
- AI implementation in customer support achieved high resolution rates.
- Cash reserves stood at $11.27 million at the end of December 2025.
- The company is on track to reach regional break-even by the end of FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Renascor Resources Limited (RNU) ORDINARY FULLY PAID |
Materials |
$163 |
PSG Demonstration Facility Update
|
29 Jan 2026 9:21AM |
$0.093 |
$0.064 |
fallen by
31.18%
|
|
RNU - Price-sensitive ASX Announcement
Full Release
Key Points
- Renascor Resources Limited updates on PSG Demonstration Facility.
- Facility part of the Siviour Project advancement.
- Focus on enhancing production of purified spherical graphite (PSG).
- Key component for lithium-ion batteries.
- Step in establishing a vertically integrated graphite business.
- Aligned with renewable energy and electric vehicle markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| First Graphene Limited (FGR) ORDINARY FULLY PAID |
Materials |
$54 |
First production of graphene enhanced concrete roof tiles
|
29 Jan 2026 9:20AM |
$0.090 |
$0.061 |
fallen by
32.22%
|
|
FGR - Price-sensitive ASX Announcement
Full Release
Key Points
- FP McCann completed the first trial batch of 2,500 graphene-enhanced concrete roof tiles.
- First Graphene's partner, Breedon Group, produced approximately 600 tonnes of graphene-enhanced cement.
- Graphene-enhanced cement offers reduced carbon emissions and improved durability.
- The trial production was conducted using FP McCann’s standard methods without changes.
- First Graphene targets the UK concrete roof tile industry valued at US$7.67 billion.
- Graphene-enhanced cement reduces moisture absorption and improves resistance to sulphate attack.
- The UK's construction sector demands low-carbon, high-performance building materials.
- FP McCann's production capability equates to approximately 170 homes per day.
- First Graphene collaborates on projects in Australia, South Africa, Thailand, and Europe.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Broken Hill Mines Limited (BHM) ORDINARY FULLY PAID |
Materials |
$104 |
Quarterly Activities Report and Appendix 5B
|
29 Jan 2026 9:20AM |
$1.290 |
$0.640 |
fallen by
50.39%
|
|
BHM - Price-sensitive ASX Announcement
Full Release
Key Points
- BHM continued to compile and digitize historical data for an updated Mineral Resource Estimate (MRE) planned for 2026.
- Drilling activities at Pinnacles completed about 8,500m, targeting open pit expansion and other areas.
- Significant high-grade polymetallic intercepts reported from FY26 drilling program.
- Rasp Mine drilling for the quarter resulted in approximately 9,000m completed with high-grade silver assays.
- Financial metrics indicated strong sales revenue and operational activities.
- Appointment of new Geology Manager to enhance resource and development strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genesis Minerals Limited (GMD) ORDINARY FULLY PAID |
Materials |
$6,111 |
Quarterly Activities Report - December 2025
|
29 Jan 2026 9:19AM |
$8.130 |
$5.350 |
fallen by
34.19%
|
|
GMD - Price-sensitive ASX Announcement
Full Release
Key Points
- Record gold production of 74,261 ounces at A$2,635/oz.
- ASPIRE 400 strategy aims to accelerate growth.
- Tower Hill project development ahead of schedule.
- Cash position at A$342 million with no corporate debt.
- Net profit after tax between A$235 million and A$245 million.
- Sustainability efforts include agreements with traditional owners.
- Major agreements to shorten Leonora rail line for mill expansion.
- FY26 growth capital outlook increased to A$220-240 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sylvania Resources Limited (SLV) ORDINARY FULLY PAID |
Materials |
$225 |
PDS dated 13 January 2026
|
29 Jan 2026 9:19AM |
$0.745 |
$0.745 |
fallen by
0%
|
|
| Beam Communications Holdings Limited (BCC) ORDINARY FULLY PAID |
Information Technology |
$15 |
BCC December 2025 Quarterly Activities Report & Appendix 4C
|
29 Jan 2026 9:19AM |
$0.155 |
$0.175 |
risen by
12.90%
|
|
BCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Healthy cash position with $4 million in available funds, increasing by US$9 million from Zoleo Inc. divestment.
- Legacy businesses generated a positive adjusted free cash flow of $0.3 million.
- Strong cost control countered expected revenue drops due to Zoleo divestment.
- Anticipated positive free adjusted cash flows for FY26.
- Quarterly revenue declined to $3.3 million due to the absence of ZOLEO device orders.
- Core equipment business revenue fell 41.1% and SatPhone Shop revenue dropped 20.8% compared to PCP.
- Recurring revenue from Airtime Services increased by 17.4%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Critical Resources Limited (CRR) ORDINARY FULLY PAID |
Materials |
$22 |
Proposed issue of securities - CRR
|
29 Jan 2026 9:18AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
| Critical Resources Limited (CRR) ORDINARY FULLY PAID |
Materials |
$22 |
Critical Resources Secures $1.75M Placement
|
29 Jan 2026 9:18AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
CRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Critical Resources Limited secured $1.75 million through a placement.
- 175 million ordinary shares issued at $0.01 each.
- 1-for-4 attaching options exercisable at $0.008, expiring 23 April 2028.
- Funds to advance Mavis Lake Lithium Project, gold and antimony exploration, and lithium-ion battery program.
- Placement completed at no discount to the last share price.
- Board and management invested $250,000, pending shareholder approval.
- 62 Capital Pty Ltd acted as Sole Lead Manager.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$8 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 9:18AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
BIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of Sedarex Limited and $2.5M capital raising.
- Completion of a two-tranche Placement raising $1 million.
- Completion of an Entitlement offer raising $645,861.
- BIT-HBV001 showed superior anti-HBV activity compared to Tenofovir.
- Patent application filed for BIT-HBV001.
- Research and development expenses totaled $100,000; staff costs were $166,000.
- Cash equivalents at the end of the period were $1,643,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$465 |
December 2025 Quarterly Activity Report and Appendix 4C
|
29 Jan 2026 9:17AM |
$2.420 |
$2.560 |
risen by
5.79%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Racura Oncology Ltd released its December 2025 Quarterly Activity Report and Appendix 4C.
- Racura announced the discovery of the primary mechanism of action of (E,E)-bisantrene, an important anticancer agent.
- The company's lead asset, RCDS1, primarily functions by binding to G4-DNA & RNA structures.
- Racura announced new clinical programs in mutant epidermal growth factor receptor non-small cell lung cancer and acute myeloid leukaemia.
- Racura underwent a name change from Race Oncology Limited to Racura Oncology Ltd.
- The company raised $3.22 million through a private placement and held a strong cash balance of $20.94 million as of 31 December 2025.
- Racura received significant R&D Tax Incentive funding from the Australian Taxation Office.
- The company engaged Beyond Drug Development to support the HARNESS-1 Phase 1a/b clinical trial.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$52 |
Investor Update Presentation - January 2026
|
29 Jan 2026 9:16AM |
$0.145 |
$0.100 |
fallen by
31.03%
|
|
| Grand Gulf Energy Limited (GGE) ORDINARY FULLY PAID |
Energy |
$9 |
Trading Halt
|
29 Jan 2026 9:16AM |
$0.002 |
$0.003 |
risen by
50%
|
|
GGE - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Grand Gulf Energy Limited (ASX: GGE).
- Pending announcement on exploration rights and capital raising.
- Trading halt effective until 2 February 2026 or announcement release.
- Company focuses on helium exploration in North America.
- Grand Gulf Energy's Red Helium project is located in Utah's Paradox Basin.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
